Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 276 trials across Europe, recruiting first
Study on the Long-Term Safety of Nintedanib for Children and Adolescents with Interstitial Lung Disease
BelgiumStudy on the Effectiveness and Safety of Cisplatin, Carboplatin, Etoposide, and Durvalumab in Patients with Limited Stage Small Cell Lung Cancer
GermanyStudy of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older
BelgiumStudy of Pembrolizumab and Lenvatinib for Patients with Resectable Non-Small-Cell Lung Cancer
AustriaStudy of reduced pembrolizumab dosing compared to standard dose in patients with advanced non-small cell lung cancer
The NetherlandsStudy on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
FinlandStudy on the Effect of Allopurinol and Hypothermia for Newborns with Hypoxic-Ischemic Encephalopathy
AustriaStudy on Sotatercept for Treating Pulmonary Hypertension in Adults with Heart Failure
BelgiumStudy of Patritumab Deruxtecan for Patients with Previously Treated Metastatic or Locally Advanced EGFR-Mutated Non-Small Cell Lung Cancer
BelgiumStudy of Nivolumab alone or combined with Ipilimumab for patients with advanced solid tumors (breast, gastric, pancreatic, lung, bladder, or ovarian cancer)
GermanyStudy on the Effects of Methylprednisolone and Placebo on Ventilator Support Duration in Severe COPD Patients in Intensive Care
FranceStudy on Long-Term Safety and Effectiveness of Treprostinil Palmitil for Patients with Pulmonary Arterial Hypertension
AustriaThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
